1-20 of 1,844 results for subject:"Blood transfusions"
Librarians' tools
- Search time
- 0.354 seconds
- Solr query time
- 0.007 seconds
- Search query
- subject:"Blood transfusions"
- We searched for
- subject_t:"Blood transfusions" OR subject_t:Apheresis OR subject_ses:90358
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
The Infected Blood Public Inquiry recommended that the government should set up a compensation scheme for those infected and affected by contaminated blood, blood products and tissue. The government accepted this recommendation and made regulations to establish the Infected Blood Compensation Scheme in August 2024.
The Infected Blood Public Inquiry recommended that the government should set up a compensation scheme for those infected and affected by contaminated blood, blood products and tissue. The government accepted this recommendation and made regulations to establish the Infected Blood Compensation Scheme in August 2024.
The Infected Blood Inquiry made recommendations to improve patient care and safety, and strengthen the voice of patients in the healthcare system.
The Infected Blood Inquiry made recommendations to improve patient care and safety, and strengthen the voice of patients in the healthcare system.
Find out about who is eligible for infected blood compensation, how the scheme processes claims for compensation and support for claimants.
Find out about who is eligible for infected blood compensation, how the scheme processes claims for compensation and support for claimants.
To ask the Secretary of State for Defence, with reference to adjournment debate of Tuesday 11 November 2025 entitled Blood Transfusions during the Falklands War, what plans his Department has to investigate Argentine blood transfusions to British service personnel aboard SS Uganda during the Falklands war.
To ask the Secretary of State for Defence, with reference to adjournment debate of Tuesday 11 November 2025 entitled Blood Transfusions during the Falklands War, what plans his Department has to investigate Argentine blood transfusions to British service personnel aboard SS Uganda during the Falklands war.
As I wrote to my hon. Friend on 18 December 2026, the Department will review the evidence he has presented in the coming months. Having conducted a search, we determined the Ministry of Defence (MOD) does not hold information relating to Argentine blood transfusions to British Service personnel aboard SS Uganda during the Falklands war. However, the Surgeon General for the Armed Forces is further investigating this matter.
I encourage individuals who believe they may have received infected blood in the course of Armed Forces treatment overseas, including veterans of the Falklands War, to contact the Infected Blood Compensation Authority (IBCA).
As with all cases, evidence will be assessed on the balance of probabilities, meaning the IBCA will need to be satisfied that it is more likely than not that the person got their infection from blood or a blood product as opposed to another route.
Agreed to on question.
Agreed to on question.
It is an honour to follow the debate we just had in this House on remembrance and the contribution of the armed forces, and to have joined the public in marking Remembrance Sunday at St George’s Hall in Liverpool this weekend.
I am grateful for the opportunity to lead this debate...
It is an honour to follow the debate we just had in this House on remembrance and the contribution of the armed forces, and to have joined the public in marking Remembrance Sunday at St George’s Hall in Liverpool this weekend.
I am grateful for the opportunity to lead this debate...
I commend the hon. Member on securing this debate, and I spoke to him beforehand. Does he not agree that the story of these British servicemen saved through blood donations from the ARA hospital ship is one of those times when honour in war was demonstrated? Does he not further...
I commend the hon. Member on securing this debate, and I spoke to him beforehand. Does he not agree that the story of these British servicemen saved through blood donations from the ARA hospital ship is one of those times when honour in war was demonstrated? Does he not further...
Absolutely, and I will develop the hon. Gentleman’s points.
To return to the story of my constituent, after that 10-hour delay and his move to the SS Uganda, he recalls waking from surgery to a nurse at his bedside who told him—I am quoting from his own testimony—that he had been
“filled...
Absolutely, and I will develop the hon. Gentleman’s points.
To return to the story of my constituent, after that 10-hour delay and his move to the SS Uganda, he recalls waking from surgery to a nurse at his bedside who told him—I am quoting from his own testimony—that he had been
“filled...
I thank my hon. Friend the Member for Liverpool Walton (Dan Carden) for securing this important debate and for raising the case of his constituent. It is rather apt that we are holding this debate on Armistice Day and so soon after Remembrance Sunday, when people the length and breadth...
I thank my hon. Friend the Member for Liverpool Walton (Dan Carden) for securing this important debate and for raising the case of his constituent. It is rather apt that we are holding this debate on Armistice Day and so soon after Remembrance Sunday, when people the length and breadth...
As an officer of the all-party parliamentary group on haemophilia and contaminated blood, I would like to confirm, in support of what the Minister is saying and the advice she is giving, that the contact I have had with IBCA has been very positive. It seems to want to engage...
As an officer of the all-party parliamentary group on haemophilia and contaminated blood, I would like to confirm, in support of what the Minister is saying and the advice she is giving, that the contact I have had with IBCA has been very positive. It seems to want to engage...
I thank the right hon. Member for his intervention.
In relation specifically to blood transfusions aboard SS Uganda during the Falklands war, the MOD has made extensive inquiries and concluded that it does not hold information in relation to these. I reiterate that I am speaking about MOD files rather than...
I thank the right hon. Member for his intervention.
In relation specifically to blood transfusions aboard SS Uganda during the Falklands war, the MOD has made extensive inquiries and concluded that it does not hold information in relation to these. I reiterate that I am speaking about MOD files rather than...
I am grateful to the Minister and to the right hon. Member for New Forest East (Sir Julian Lewis) for their guidance. My constituent is frustrated; he has done extensive research, spoken to many people and been able to amass evidence, and I think what he would really appreciate is...
I am grateful to the Minister and to the right hon. Member for New Forest East (Sir Julian Lewis) for their guidance. My constituent is frustrated; he has done extensive research, spoken to many people and been able to amass evidence, and I think what he would really appreciate is...
I will come to that point in a moment.
To reiterate, the MOD veterans welfare service supports veterans and their dependants with increasing needs around disability, housing and subsistence, and the war pension scheme is available for service-related injuries and conditions.
When I served, I wanted to know that I would receive...
I will come to that point in a moment.
To reiterate, the MOD veterans welfare service supports veterans and their dependants with increasing needs around disability, housing and subsistence, and the war pension scheme is available for service-related injuries and conditions.
When I served, I wanted to know that I would receive...
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the NHS on its policy of informing Sickle Cell patients when they are not given Ro matched blood.
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the NHS on its policy of informing Sickle Cell patients when they are not given Ro matched blood.
DHSC are working in partnership with NHS Blood and Transplant, NHS England and the National Blood Transfusion Committee to deliver on the recommendations detailed in the infected blood inquiry, which includes improving digital patient records and communications for patients receiving transfusions. A blood genotyping programme has also been introduced, enabling detection of previously undetectable antibodies that could cause complications. To meet the clinical need to provide better matched blood for patients with conditions like sickle cell disorder, NHS Blood and Transplant is actively recruiting donors from Black heritage backgrounds.
To ask the Secretary of State for Health and Social Care, , how many sickle cell patients have developed haemolysis due to receiving a blood transfusion with unmatched blood during the last 12 months.
To ask the Secretary of State for Health and Social Care, , how many sickle cell patients have developed haemolysis due to receiving a blood transfusion with unmatched blood during the last 12 months.
Serious Hazards of Transfusion (SHOT) is the United Kingdom’s independent, professionally led haemovigilance scheme. SHOT collects and analyses information on adverse events and reactions in blood transfusion from all healthcare organisations that are involved in the transfusion of blood components and specific blood products in the United Kingdom. Further information on SHOT is available at the following link:
The latest data available on haemolytic transfusion reactions was published in the Annual SHOT Report 2024. The report reviews reactions reported to SHOT from January to December 2024, and is available at the following link:
https://www.shotuk.org/shot-reports/annual-shot-report-2024/#annual-shot
Over the year, based on the available data, a total of 51 haemolytic transfusion reactions were reported. No errors were reported during the provision of blood components, meaning in all cases blood was appropriately matched, including safe substitutions where necessary, according to the patient requirements and clinical situation, as per British Society for Haematology’s guidelines, which are available at the following link:
To ask the Secretary of State for Health and Social Care, how many patients with (a) leukaemia and lymphoma, (b) myeloma, (c) other cancers, (d) myelodysplastic syndromes, (e) aplastic anemia, (f) thalassemia, (g) bleeding disorders and (h) other conditions which require regular blood transfusions have developed haemolysis due to receiving...
To ask the Secretary of State for Health and Social Care, how many patients with (a) leukaemia and lymphoma, (b) myeloma, (c) other cancers, (d) myelodysplastic syndromes, (e) aplastic anemia, (f) thalassemia, (g) bleeding disorders and (h) other conditions which require regular blood transfusions have developed haemolysis due to receiving...
Serious Hazards of Transfusion (SHOT) is the United Kingdom’s independent, professionally led haemovigilance scheme. SHOT collects and analyses information on adverse events and reactions in blood transfusion from all healthcare organisations that are involved in the transfusion of blood components and specific blood products in the United Kingdom. Further information on SHOT is available at the following link:
The latest data available on haemolytic transfusion reactions was published in the Annual SHOT Report 2024. The report reviews reactions reported to SHOT from January to December 2024, and is available at the following link:
https://www.shotuk.org/shot-reports/annual-shot-report-2024/#annual-shot
Over the year, based on the available data, a total of 51 haemolytic transfusion reactions were reported. No errors were reported during the provision of blood components, meaning in all cases blood was appropriately matched, including safe substitutions where necessary, according to the patient requirements and clinical situation, as per British Society for Haematology’s guidelines, which are available at the following link:
To ask His Majesty's Government when they will publish the findings of the review undertaken by the apheresis working group.
To ask His Majesty's Government when they will publish the findings of the review undertaken by the apheresis working group.
The apheresis working group was established in 2024 to provide independent advice to the Department on issues around apheresis capacity and the resilience of the United Kingdom’s stem cell supply. The group has submitted an internal, interim report to ministers for consideration and is currently working to gather additional data to strengthen the evidence base of this report, before proceeding to publication.
To ask His Majesty's Government whether the apheresis working group plans to consult external stakeholders, including patient organisations and the life sciences industry, prior to publishing the apheresis review.
To ask His Majesty's Government whether the apheresis working group plans to consult external stakeholders, including patient organisations and the life sciences industry, prior to publishing the apheresis review.
The apheresis working group was established in 2024 to provide independent advice to the Department on issues around apheresis capacity and the resilience of the United Kingdom’s stem cell supply. Membership includes the UK aligned stem cell registry, health professionals, and service providers. Stakeholder views have been captured through member organisations, including the Cell and Gene Therapy Catapult and blood cancer charities, and industry representatives have also been invited to present at meetings of the group.
There are no plans to consult external stakeholders prior to the publication of the group’s review of apheresis capacity. The group will look at options for formalising feedback following publication.
To ask the Secretary of State for Health and Social Care, what steps his Department is with manufacturers of blood transfusion sampling bottles to improve their design.
To ask the Secretary of State for Health and Social Care, what steps his Department is with manufacturers of blood transfusion sampling bottles to improve their design.
NHS Blood and Transplant (NHSBT) is responsible for collecting and processing blood donations across England, to meet hospital demand for treating patients.
Blood collection tubes are used to collect blood samples at the time of blood donation. These samples are used to perform mandatory and discretionary infectious disease marker screening and blood grouping at every donation. Additional samples are taken from apheresis donors for tests such as haemoglobin levels, total protein testing. Sample tubes are also used for quality monitoring of components.
NHSBT is not aware of any issues surrounding the current containers and is therefore not actively working with manufacturers of blood transfusion sampling bottles, as the current design meets their needs.
To ask the Secretary of State for Health and Social Care, how many sickle cell patients (a) with and (b) without the Ro subtype were unable to receive a matching transfusion due to low supplies in the last 12 months.
To ask the Secretary of State for Health and Social Care, how many sickle cell patients (a) with and (b) without the Ro subtype were unable to receive a matching transfusion due to low supplies in the last 12 months.
NHS Blood and Transplant is responsible for collection of blood donations and supply of blood and blood products to hospitals to meet patient need in England.
Data is not held centrally on the purpose for which each blood product is requested and supplied.